Journals / Akdeniz Tıp Dergisi / 2021 / Cilt: 7 - Sayı: 1

Effects of Vitamin D on Pain Severity, Quality of Life, Depression and Sleep in Patients with Fibromyalgia

Fibromiyaljili Hastalarda Vitamin Dʼnin Ağrı Şiddeti, Yaşam Kalitesi, Depresyon ve Uyku Üzerine Etkileri

Pages
89–95
Publication Date
2022-10-11
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Objective: The aim of this study was to investigate the role of 25-hydroxyvitamin D 25OHD concentrations on symptoms in the Fibromyalgia Syndrome FMS .Material and Methods: 80 female patients diagnosed with FMS were divided into 2 groups according to serum 25OHD concentration: 25OHD

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: The aim of this study was to investigate the role of 25-hydroxyvitamin D 25OHD concentrations on symptoms in the Fibromyalgia Syndrome FMS .Material and Methods: 80 female patients diagnosed with FMS were divided into 2 groups according to serum 25OHD concentration: 25OHD
📊
Key Findings & Data:Objective: The aim of this study was to investigate the role of 25-hydroxyvitamin D 25OHD concentrations on symptoms in the Fibromyalgia Syndrome FMS .Material and Methods: 80 female patients diagnosed with FMS were divided into 2 groups according to serum 25OHD concentration: 25OHD
💡
Conclusion & Impact:Objective: The aim of this study was to investigate the role of 25-hydroxyvitamin D 25OHD concentrations on symptoms in the Fibromyalgia Syndrome FMS .Material and Methods: 80 female patients diagnosed with FMS were divided into 2 groups according to serum 25OHD concentration: 25OHD
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Depresyon · Fibromiyalji · Serum 25 hidroksivitamin D

Abstract

Objective: The aim of this study was to investigate the role of 25-hydroxyvitamin D 25OHD concentrations on symptoms in the Fibromyalgia Syndrome FMS .Material and Methods: 80 female patients diagnosed with FMS were divided into 2 groups according to serum 25OHD concentration: 25OHD

Özet

Amaç: Bu çalışmanın amacı, serum 25 hidroksivitamin D konsantrasyonlarının Fibromiyalji Sendromuʼndaki FMS semptomlar üzerindeki rolünü araştırmaktır.Gereç ve Yöntemler: FMS tanısı almış 80 kadın hasta serum 25-hidroksivitamin D 25OHD konsantrasyonuna göre 2 gruba ayrıldı: 25OHD

🔖

Cite This Article

YALÇIN, Ü., GÜLOĞLU, S. B. (2022). Effects of Vitamin D on Pain Severity, Quality of Life, Depression and Sleep in Patients with Fibromyalgia. Akdeniz Tıp Dergisi, Cilt: 7 - Sayı: 1, 89–95. https://ajindex.com/articles/434254

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (11)

  1. Wolfe F, Clauw DJ, Fitzcharles M-A, Goldenberg DL, Häuser W, Katz RL, Mease PJ, Russell AS, Russell IJ, Walitt B. 2016 Revisions to the 2010/2011 fibromyalgia diagnostic criteria. Semin Arthritis Rheum 2016; 46:319-29.
  2. Ellis SD, Kelly ST, Shurlock JH, Hepburn ALN. The role of vitamin D testing and replacement in fibromyalgia: A systematic literature review. BMC Rheumatol 2018; 2:28. Baygutalp NK, Baygutalp F, Şeferoğlu B, Bakan E. The relation between serum vitamin D levels and clinical findings of fibromyalgia syndrome. Dicle Med J 2014; 41(3):446-50.
  3. Abeles AM, Pillinger MH, Solitar BM, Abeles M. Nar- rative review: The pathophysiology of fibromyalgia. Ann Intern Med 2007; 146(10):726-34.
  4. Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, Murad MH, Weaver CM. Guidelines for preventing and treating vitamin D deficiency and insufficiency revisited. J Clin Endocrinol Metab 2012; 97(4):1153-8.
  5. Okyay R, Koçyiğit B, Gürsoy S. Vitamin D levels in women with fibromyalgia and relationship between pain, tender point count and disease activity. Acta Med Medi- terr 2016; 32:243-7.
  6. Dogru A, Balkarli A, Cobankara V, Tunc SE, Sahin M. Effects of vitamin D therapy on quality of life in patients with fibromyalgia. Eurasian J Med 2017; 49(2):113-7.
  7. Altındağ O, Öğüt E, Gur A, Gursoy S, Gunay M. Serum vitamin D level and its relation with clinical parameters in fibromyalgia as a neuropathic pain. Orthop Muscular Syst 2014; 3:171. Gendelman O, Itzhaki D, Makarov S, Bennun M, Ami- tal H. A randomized double-blind placebo-controlled study adding high dose vitamin D to analgesic regimens in patients with musculoskeletal pain. Lupus 2015; 24(4- 5):483-9.
  8. Andersen ML, Tufik S. Vitamin D as an underlying factor in sleep-related issues. J Clin Sleep Med 2012; 8(6):699. McCarty DE, Reddy A, Keigley Q, Kim PY, Cohen S, Marino AA. Nonspecific pain is a marker for hypovita- minosis D in patients undergoing evaluation for sleep dis- orders: a pilot study. Nat Sci Sleep 2013; 5:37-42.
  9. Eyles DW, Liu PY, Josh P, Cui X. Intracellular distribu- tion of the vitamin D receptor in the brain: Comparison with classic target tissues and redistribution with develop- ment. Neuroscience 2014; 268:1-9.
  10. Ulusoy H, Sarica N, Arslan S, Ozyurt H, Cetin I, Birgul Ozer E, Yildirim N. Serum vitamin D status and bone mineral density in fibromyalgia. Bratisl Lek Listy 2010; 111:604-9
  11. Okumus M, Koybası M, Tuncay F, Ceceli E, Ayhan F, Yorgancioglu R, Borman P. Fibromyalgia syndrome: Is i